BCR and hydrops fetalis: Several studies [5, 34, 35]showed that BCR and BCR variation were significantly correlated with their respective adverse clinical events after renal function stratification, and then it was concluded that BCR may not be a predictor based on renal function in patients with HF, but a neurohormonal marker for predicting adverse outcomes independent of renal function (such as RAAS, AVP).